Cargando…

Finding the Right Heavy Chains for Immunostimulatory Antibodies

For twelve years, the oncology field has been revolutionized by antibodies targeting immune checkpoints. They must be considered as a heterogenous family of immunostimulatory antibodies displaying very different mechanisms of action, not only depending on the target or on the cells expressing it, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Boulard, Pierre, Gouilleux-Gruart, Valérie, Watier, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499592/
https://www.ncbi.nlm.nih.gov/pubmed/36142278
http://dx.doi.org/10.3390/ijms231810367